Clinical Trials Browser

Recruiting × Head and Neck Neoplasms × apixaban × Clear all

NCT07189897 2025-10-08

Apixaban or Enoxaparin After Head and Neck Cancer Surgery

Phase 4 Recruiting

Classical hematologyHead & Neck

Head and Neck Neoplasms, Thrombosis, Venous Thromboembolism